Celebrex, Naproxen Won't Prevent Mental Decline

Related Encyclopedia • Acoustic Neurinoma • Alzheimer's Disease • Bell's Palsy • Brain and Spinal Cord Magnetic Resonance Imaging More... Related Healthscout Videos The On-X Valve PROACT Trial The On-X Heart Valve: Longevity With Less Reliance on Coumadin Tissue Valves vs. Mechanical Valves What is the difference between heart valve repair and replacement? More... Related Animations • Alzheimer's Disease Video Animation • Erectile Dysfunction • What is a Heart Attack? More... Related Drug Information • Actonel • Adderal XR • Concerta • Coumadin More... Related News Articles • Work Strife Stresses the Heart • Abnormal Heartbeat After Bypass a Bad Sign • Lowered HRT Use May Have Cut Heart Attacks • With Peripheral Artery Disease, Med Adherence Is Low More...

Page:  << Prev | 1 | 2 | 3 | Next >>

That observation has led scientists to speculate that anti-inflammatory drugs may have an effect on the disease and, in fact, some previous observational studies have shown an association between NSAID use and a reduced risk of developing Alzheimer's.

In May 2007, the same group of researchers published findings that Celebrex and naproxen did not prevent Alzheimer's disease.

For the new study, 2,117 men and women over the age of 70 with a family history of Alzheimer's disease were randomly assigned to receive 200 milligrams of Celebrex twice a day, 220 milligrams of naproxen twice a day, or a placebo. Participants did not have a diagnosis of Alzheimer's, other dementias or mild cognitive impairment at the March 2001, start of the trial.

Text Continues Below

---

The participants' cognitive function was tested annually, but therapy was stopped in December 2004 because another study had reported an increased risk of cardiovascular problems in people taking Celebrex.

Analysis of this trial found that people taking naproxen had lower overall scores on measures of cognitive function than did men and women taking the placebo. Individuals taking naproxen or Celebrex had lower scores on a specific mental exam than did those taking a placebo.

The differences in results between this trial and previous research may have to do with the design of the study, or the results here may apply only to Celebrex and naproxen and not to other anti-inflammatory drugs such as ibuprofen, the researchers said. Or NSAIDs may only confer protection when given much earlier.

"This is speculative but there is increasing evidence that it may be a matter of timing, so by the time older adults take these drugs, if there is a protective effect, it may be past that time," Morris explained.

At this point, however, experts don't know what the best time would be to start the drugs.

Page:  << Prev | 1 | 2 | 3 | Next >>